In a report released today, Andrew Obin from Bank of America Securities reiterated a Buy rating on Dover, with a price target of $240.00.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Andrew Obin has given his Buy rating due to a combination of factors that indicate strong future performance for Dover. The company is expected to see accelerated organic revenue growth starting in the fourth quarter of 2025 and continuing into 2026. This growth is supported by strategic cost-saving measures that are projected to save $40 million in 2026, as well as a $500 million accelerated share repurchase program. These actions are anticipated to build significant earnings momentum for the company.
Additionally, Dover’s Climate & Sustainable Technologies segment has shown a notable increase in bookings, which is expected to continue its upward trend. The company is also positioned to benefit from the reshoring of US pharmaceutical manufacturing, which will positively impact its biopharma business. Furthermore, there is optimism about the growth in US gas distribution and midstream capital expenditures, which will benefit Dover’s Precision Components business. These factors contribute to a positive outlook, justifying the Buy rating and the raised price objective of $240.
In another report released on December 9, TR | OpenAI – 4o also reiterated a Buy rating on the stock with a $219.00 price target.
Based on the recent corporate insider activity of 34 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of DOV in relation to earlier this year.